This means that, theoretically, compound U-573 is capable of penetrating the brain of animals with PD and directly affecting inflammatory processes and molecular targets of neuroinflammation, including P2X7 receptors, thereby exerting a neuroprotective effect. This evidence concerns the gene P2RX7 and Parkinson disease.